Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 505Unknown 232Recruiting 229Active not recruiting 96Terminated 87Not yet recruiting 59Withdrawn 32Enrolling by invitation 15No longer available 7Available 3Suspended 2Approved for marketing 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 74Breast 39Genitourinary 29CNS 29Lymphoid 26Other hematologic neoplasm 25Thoracic 22Head & Neck 18Gynecologic 16Tumor-Agnostic 15Other solid neoplasm 11Dermatologic 10Sarcoma 9Myeloid 8Other 6Plasma cell 5Classical hematology 3Endocrine 2Other neoplasm 1NET 1

Conditions

Carcinoma, Neuroendocrine 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Mesothelioma, Malignant 1Hodgkin Disease 1Gallbladder Neoplasms 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

tivozanib 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × OTHER × Endocrine × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

University of Florida

Phase 1/2 Suspended
29 enrolled
BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡